NYSE - Nasdaq Real Time Price USD

ResMed Inc. (RMD)

Compare
211.73 -0.65 (-0.31%)
At close: June 14 at 4:00 PM EDT
211.15 -0.58 (-0.27%)
After hours: June 14 at 6:14 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Total Revenue
4,584,159.00
4,222,993.00
3,578,127.00
3,196,825.00
2,957,013.00
--
Cost of Revenue
2,026,996.00
1,867,331.00
1,553,816.00
1,357,725.00
1,239,227.00
--
Gross Profit
2,557,163.00
2,355,662.00
2,024,311.00
1,839,100.00
1,717,786.00
--
Operating Expense
1,268,020.00
1,203,665.00
1,022,161.00
926,749.00
908,727.00
--
Operating Income
1,289,143.00
1,151,997.00
1,002,150.00
912,351.00
809,059.00
--
Net Non Operating Interest Income Expense
-54,730.00
-47,379.00
-22,312.00
-23,627.00
-39,356.00
--
Other Income Expense
-50,545.00
-2,954.00
-19,355.00
-5,062.00
-36,615.00
--
Pretax Income
1,183,868.00
1,101,664.00
960,483.00
883,662.00
733,088.00
--
Tax Provision
225,489.00
204,108.00
181,046.00
409,157.00
111,414.00
--
Net Income Common Stockholders
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
--
Diluted NI Available to Com Stockholders
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
--
Basic EPS
6.53
6.12
5.34
3.27
4.31
--
Diluted EPS
6.50
6.09
5.30
3.24
4.27
--
Basic Average Shares
147,046.25
146,765.00
146,066.00
145,313.00
144,338.00
--
Diluted Average Shares
147,566.75
147,455.00
147,043.00
146,451.00
145,652.00
--
Total Operating Income as Reported
1,213,946.00
1,131,871.00
1,000,286.00
903,678.00
809,659.00
--
Total Expenses
3,295,016.00
3,070,996.00
2,575,977.00
2,284,474.00
2,147,954.00
--
Net Income from Continuing & Discontinued Operation
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
--
Normalized Income
1,002,878.97
897,473.69
780,950.57
480,836.29
621,165.19
--
Interest Income
--
--
--
362.00
1,021.00
2,299.00
Interest Expense
--
--
--
23,989.00
40,377.00
36,156.00
Net Interest Income
-54,730.00
-47,379.00
-22,312.00
-23,627.00
-39,356.00
--
EBIT
1,289,143.00
1,151,997.00
1,002,150.00
912,351.00
809,059.00
--
EBITDA
1,505,796.00
1,349,559.00
1,195,991.00
1,103,869.00
990,432.00
--
Reconciled Cost of Revenue
1,857,921.00
1,711,789.00
1,391,053.00
1,197,285.00
1,087,946.00
--
Reconciled Depreciation
216,653.00
197,562.00
193,841.00
191,518.00
181,373.00
--
Net Income from Continuing Operation Net Minority Interest
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
--
Total Unusual Items Excluding Goodwill
-54,970.00
101.00
-1,864.00
-8,673.00
600.00
--
Total Unusual Items
-54,970.00
101.00
-1,864.00
-8,673.00
600.00
--
Normalized EBITDA
1,560,766.00
1,349,458.00
1,197,855.00
1,112,542.00
989,832.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-10,470.03
18.69
-350.43
-2,341.71
91.19
--
6/30/2019 - 6/2/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WST West Pharmaceutical Services, Inc.
333.25
-0.90%
 
COO The Cooper Companies, Inc.
93.47
-0.77%
 
BDX Becton, Dickinson and Company
233.73
+0.76%
 
RGEN Repligen Corporation
125.62
-0.25%
 
HOLX Hologic, Inc.
71.79
-0.49%
 
TFX Teleflex Incorporated
208.29
-0.48%
 
LMAT LeMaitre Vascular, Inc.
80.09
+1.32%
 
ISRG Intuitive Surgical, Inc.
425.78
+0.68%
 
BAX Baxter International Inc.
33.78
+0.12%
 
MMSI Merit Medical Systems, Inc.
81.80
-1.12%